3,4-Methylenedioxy-N-propylamphetamine

3,4-Methylenedioxy-N-propylamphetamine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

3,4-Methylenedioxy-N-propylamphetamine (MDPR) is a psychedelic and entactogen of the amphetamine class. It is structurally related to 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are well-known psychoactive substances.

Chemical structure and properties[edit]

3,4-Methylenedioxy-N-propylamphetamine is a derivative of amphetamine with a methylenedioxy group attached to the phenyl ring and a propyl group attached to the nitrogen atom. The chemical formula is C₁₃H₁₉NO₂.

Pharmacology[edit]

MDPR acts as a serotonin releasing agent, similar to other compounds in the methylenedioxyamphetamine family. It is believed to increase the levels of serotonin in the brain, leading to its psychoactive effects. The exact mechanism of action and the receptor affinities of MDPR are not well-documented.

Effects[edit]

The effects of 3,4-Methylenedioxy-N-propylamphetamine are not well-studied, but it is presumed to have effects similar to those of other entactogens and psychedelics, such as MDMA. These effects may include altered mood, enhanced sensory perception, and increased empathy and sociability.

Legal status[edit]

The legal status of MDPR varies by country. In many jurisdictions, it may be considered a controlled substance due to its structural similarity to other regulated amphetamines.

Synthesis[edit]

The synthesis of 3,4-Methylenedioxy-N-propylamphetamine involves the reaction of 3,4-methylenedioxyphenylacetone with propylamine. This process is similar to the synthesis of other methylenedioxyamphetamines.

Related compounds[edit]

3,4-Methylenedioxyamphetamine (MDA)
3,4-Methylenedioxymethamphetamine (MDMA)
3,4-Methylenedioxy-N-methylamphetamine (MDMA)
3,4-Methylenedioxy-N-ethylamphetamine (MDEA)

Related pages[edit]